(2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg) + Placebo
2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| (2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg) + Placebo for depressive disorder, treatment-resistant | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| (2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg) + Placebo for major depressive disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |